TYP 14.9% 5.4¢ tryptamine therapeutics limited

Tell me another one....

  1. 132 Posts.
    lightbulb Created with Sketch. 19
    Guess the smart money must think differently about EX1's claims to having the leading technology in exosomes with Lonza buying Codiak's exosome manufacturing facility. Lonza has also recently bought Exosomics. So this is the year we LEAP. Yep, sure.
 
watchlist Created with Sketch. Add TYP (ASX) to my watchlist
(20min delay)
Last
5.4¢
Change
0.007(14.9%)
Mkt cap ! $63.78M
Open High Low Value Volume
4.8¢ 5.7¢ 4.7¢ $523.5K 10.18M

Buyers (Bids)

No. Vol. Price($)
1 6200 5.4¢
 

Sellers (Offers)

Price($) Vol. No.
5.5¢ 150000 2
View Market Depth
Last trade - 16.10pm 13/11/2024 (20 minute delay) ?
TYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.